Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**TamaFlex Complete** is an over-the-counter **multi-ingredient nutraceutical dietary supplement** for joint health support marketed by **GNC**. It combines the proprietary botanical blend **TamaFlex** with **glucosamine**, **chondroitin**, **undenatured type II collagen**, and **hyaluronic acid**. TamaFlex itself is a 2:1 blend of **tamarind seed extract** from *Tamarindus indica* and **turmeric root extract** from *Curcuma longa*. Rather than acting as a single-target pharmaceutical, the product is intended to support joint comfort, flexibility, stiffness, mobility, structure, and function through multi-component anti-inflammatory and antioxidant effects, including reported modulation of the **cyclooxygenase-2** and **5-lipoxygenase** inflammatory pathways together with structural joint-support ingredients. It is not an FDA-approved therapeutic drug for a specific disease indication.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on TamaFlex Complete.